
450.72 Delayed Data As of Sep 21 | ![]() Today’s Change | 412.00 Today|||52-Week Range 549.52 | -12.14% Year-to-Date |
The 19 analysts offering 12-month price forecasts for Elevance Health Inc have a median target of 569.00, with a high estimate of 629.00 and a low estimate of 493.00. The median estimate represents a +26.24% increase from the last price of 450.72.
The current consensus among 23 polled investment analysts is to Buy stock in Elevance Health Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.